clinical-toolkit

Use when estimating cardiovascular risk, stroke risk in atrial fibrillation, bleeding risk, pneumonia severity (CURB-65), or venous thromboembolism probability (Wells DVT/PE). Includes ASCVD PCE, CHA2DS2-VASc, HAS-BLED, Framingham, HEART, CURB-65, and Wells scores.

Use when assessing critical illness severity or neurologic status. Includes GCS, SOFA/qSOFA, MELD, NIHSS, and APACHE IV overview.

Use when applying validated ED decision rules to reduce unnecessary imaging or testing. Includes Ottawa ankle/knee rules, Canadian C-Spine rule, and the PERC rule.

Use when assessing medication appropriateness in older adults or screening for delirium or cognitive impairment. Includes STOPP/START v3, 4AT delirium screen, and Mini-Cog.

Use when calculating medication conversions or safety metrics. Includes corticosteroid equivalencies, QTc correction formulas, opioid equianalgesic conversions, and warfarin dosing adjustment guidance.

Use when applying pediatric decision rules or growth/weight-based calculations. Includes PECARN head injury rule, CDC/WHO growth standards, weight-based dosing rules, Holliday-Segar maintenance fluids, and Parkland burn formula.

Use when calculating general primary care formulas and decision rules. Includes TDEE/BMR (Mifflin-St Jeor, Harris-Benedict), Centor/McIsaac, and Naegele's rule.

Use when calculating renal function estimates, electrolyte corrections, acid-base physiology metrics, lipid estimates, or BMI. Includes CKD-EPI 2021, Cockcroft-Gault, anion gap, Winters formula, A-a gradient, Friedewald LDL, and related tools.

Use when screening for anxiety symptoms (excessive worry, restlessness, difficulty concentrating, muscle tension, panic attacks), differentiating anxiety disorders, assessing treatment response, or patient reports overwhelming fear or avoidance behaviors. Provides GAD-7 (comprehensive) and GAD-2 (brief) assessments.

Use when you need a structured, non-validated interview guide for bipolar risk factors and mood elevation history. Not a diagnostic or validated instrument.

Use when you need a structured, non-validated intake for cognitive concerns. Not a validated cognitive screening instrument.

Use when screening for depression symptoms (low mood, anhedonia, fatigue, sleep changes, appetite changes), assessing severity for treatment planning, tracking treatment response, or patient has positive PHQ-9 Item 9 (suicidal ideation). Provides PHQ-9 (comprehensive) and PHQ-2 (brief) assessments.

Use when screening for nonspecific psychological distress or tracking symptom burden over time. Provides K6 and K10 scales with scoring and interpretation guidance.

Use when you need a structured, non-validated checklist for eating disorder risk factors and medical red flags. Not a validated screening tool.

Use when you need a structured, non-validated interview for functional impact across work, social, and home domains. Not a validated instrument.

Use when conducting initial patient intake, gathering comprehensive history, establishing therapeutic rapport, assessing safety and risk factors, or need structured interview framework. Provides HEADSS assessment (adolescents), biopsychosocial interview template, and safety protocols.

Use when assessing readiness to change, planning behavioral interventions, or matching treatment approach to patient motivation. Provides URICA access guidance and a brief readiness ruler with stage-based guidance.

Use when calculating daily morphine milligram equivalents (MME) to assess opioid dose risk, document totals, or support taper planning. Based on CDC conversion factors and safety cautions.

Use when assessing sleep patterns over time, monitoring insomnia treatment response, or establishing baseline sleep behavior. Provides guidance for the Consensus Sleep Diary (CSD) and a summary workflow.

Use when screening for alcohol or drug use concerns (heavy drinking, cravings, loss of control, withdrawal symptoms, functional impairment), assessing substance use severity, determining level of care, or patient reports substance-related problems. Provides AUDIT-C (alcohol brief) and DAST-10 (drugs comprehensive) assessments.

Use when screening for suicide risk (suicidal thoughts, self-harm urges, hopelessness, plans or intent to die), patient has positive PHQ-9 Item 9, recent suicide attempt, psychiatric crisis, or establishing safety planning. Provides ASQ (brief) and C-SSRS Columbia Protocol (comprehensive risk assessment). Critical safety-focused.

Use when screening for PTSD and trauma-related symptoms (intrusive memories, flashbacks, nightmares, avoidance, hypervigilance, emotional numbing), patient reports traumatic exposure, assessing trauma severity, or using trauma-informed approaches. Provides PC-PTSD-5 (brief) and PCL-5 (comprehensive) assessments.

Use when developing treatment plans, writing SMART goals, determining appropriate level of care, implementing measurement-based care protocols, or adapting treatment based on patient progress. Provides SMART goals framework, ASAM/LOCUS criteria guidance, and treatment monitoring strategies.

Use when time is limited and you need a rapid combined depression and anxiety screen. Provides PHQ-4 (PHQ-2 + GAD-2) with interpretation and triage guidance.

Use when assessing subjective well-being or tracking recovery alongside symptom measures. Provides WHO-5 Well-Being Index with scoring and interpretation guidance.